73 - Reinventing a Legacy Brand Without Losing the People Who Built It w/AABB CEO Debra BenAvram

Welcome to Digital Doorways, the podcast where we go deep with the CEOs and CMOs shaping the future of business. I'm Jason Siegel, founder of Bluetext, a B2B branding and marketing agency in Washington, D.C.Today's guest is one of the most accomplished association executives in the country and a fellow YPO member right here in D.C. ⁠Debra BenAvram⁠ has spent more than 20 years leading mission-driven organizations, and she has done something very few CEOs pull off: taken a legacy brand the world already knew and made it new again without losing what made it matter.She is the CEO of AABB, the Association for the Advancement of Blood and Biotherapies, where she doubled margins, launched the first certification for advanced biotherapies professionals, drove historic U.S. blood donor policy changes, and led a full rebrand in 2022. She was just named the 2025 Professional Society Association Executive of the Year.Debra welcome to Digital Doorways.Mission and MotivationYou have spent your entire career inside mission-driven organizations. What draws you to that model, and what does it give you as a leader that a purely commercial company wouldn't?AABB sits at the intersection of science, public health, and global policy. For people who don't know the organization, how do you describe what it actually does and why it matters?Blood and biotherapies don't always capture headlines the way other healthcare sectors do. How do you make people care about a mission that is quietly keeping millions of people alive?The Rebrand: Making a Legacy Brand NewIn 2022 you led a full renaming and rebrand of an organization with decades of history behind its original name. What made you decide the moment had come to do that?Rebrands inside membership organizations are notoriously political. You have to bring thousands of members along, not just a board of directors. How did you manage that stakeholder challenge?What did you learn about your own organization through the process of trying to explain it to the outside world in a new way?The new name, Association for the Advancement of Blood and Biotherapies, is designed to signal a future-facing field, not just a legacy one. How do you balance honoring where you came from with staking a claim on where the industry is going?Growth and StrategyYou doubled margins in flagship programs while also expanding into new territory. How do you hold financial discipline and strategic boldness at the same time inside a nonprofit?You created the first certification for advanced biotherapies professionals. What does it take to launch something genuinely industry-first inside an organization with established programs and constituents?You led the push for individual donor assessment to replace blanket blood donation restrictions that had been in place for decades. That was a major policy win. How do you build the kind of advocacy muscle needed to change national policy?CEO CraftYou have been a CEO across multiple organizations for more than 17 years. What have you learned about the job that you couldn't have known when you started?You have written and spoken extensively about organizational culture. You have said that culture eats strategy for breakfast. What does that look like in practice inside AABB today?Association CEOs answer to member volunteers on their boards, not to a traditional investor or owner. How do you lead with authority inside a governance structure that is deliberately designed to be collective?Personal LeadershipYou were recognized as a 40 Under 40 leader before you were 35. Looking back, what risks did you take early in your career that most people your age weren't willing to take?You co-authored an op-ed in Modern Healthcare with Sheryl Sandberg on blood donation policy. How do you think about building the kinds of coalitions and relationships that make moments like that possible?